Streamex Corp. current report, 21 February 2023

SEC Filing Summary: BioSig Technologies, Inc. (BSGM)

Business Context and Reporting Period

This Form 8-K Current Report was filed by BioSig Technologies, Inc. on February 22, 2023, covering events reported as of February 21, 2023. The filing addresses the company's compliance status with The Nasdaq Capital Market listing requirements following previous notices of non-compliance regarding bid price and stockholders' equity.

Key Financial Metrics

The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory compliance metrics related to stock listing standards.

Material Changes and Compliance Status

  • Bid Price Requirement: The company regained compliance with Nasdaq Listing Rule 5550(a)(2). The common stock closed at or above $1.00 per share for 10 consecutive business days (February 6, 2023, to February 17, 2023).
  • Market Value of Listed Securities (MVLS): The company regained compliance with an Alternative Compliance Standard. The MVLS was $35 million or greater for 11 consecutive business days (January 31, 2023, to February 17, 2023).
  • Resolution: Nasdaq has officially closed both the Bid Price Requirement and the MVLS compliance matters.

Outlook, Risks, and Management Commentary

Management confirmed via a press release (Exhibit 99.1) that the company is now in compliance with continued listing requirements. The filing does not contain forward-looking guidance, new risk factors, or discussion of unusual items beyond the resolution of the listing deficiencies.

Investor Verification Checklist

  • Verify the current trading price of BSGM to ensure it remains above the $1.00 minimum bid price threshold.
  • Confirm the current Market Value of Listed Securities (MVLS) remains at or above $35 million.
  • Review the attached Press Release (Exhibit 99.1) for any additional operational updates not detailed in the 8-K text.
  • Monitor future filings for any new Nasdaq deficiency notices regarding stockholders' equity or net income, which were previously cited as non-compliant areas.